AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
68 hedge funds and large institutions have $913M invested in Ambrx Biopharma, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 9 closing their positions.
Holders
68
Holders Change
+24
Holders Change %
+54.55%
% of All Funds
1%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
34
Increased
19
Reduced
13
Closed
9
Calls
$4.72M
Puts
$3.74M
Net Calls
+$974K
Net Calls Change
-$11.9M
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Group One Trading
Chicago,
Illinois
| – | – | -2,155 | Closed |
|
77
Legal & General Group
London,
United Kingdom
| – | – | -1,381 | Closed |
|
|
GS
78
GTS Securities
New York
| – | – | – | – |
|
|
CFGS
79
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
BFM
80
Boothbay Fund Management
New York
| – | – | – | – |
|
81
Belvedere Trading
Chicago,
Illinois
| – | – | – | – |
|
|
GPP
82
Great Point Partners
Greenwich,
Connecticut
| – | – | – | – |
|
|
IC
83
Ikarian Capital
Dallas,
Texas
| – | – | – | – |
|